Dr. Reddy's Laboratories, Inc. has voluntarily recalled 73,761 bottles of Glimepiride (glimepiride) Tablets, USP 1mg, because of a misprint on the tablets. This recall involves 59,336 of the 100-count bottles and 14,425 of the 500-count bottles. The tablets are prescription medications used to treat type 2 diabetes and were distributed nationwide across the United States.
A misprint on a prescription tablet can cause patient confusion and could lead to medication errors, such as taking the wrong dose or the wrong medicine entirely. No injuries have been reported in connection with this misprint.
You have 2 options:
Recall #: D-0312-2024; Quantity: 59,336 bottles
Recall #: D-0313-2024; Quantity: 14,425 bottles
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.